Faculty & Staff Directory
Candyce Williams, MD
Candyce Williams, MD, is a specialist in the Department of Physical Medicine and Neuro-Rehabilitation at Barrow Neurological Institute in Phoenix. She focuses on neuro-rehabilitation and spinal cord injury medicine and is board certified in internal medicine, physical medicine and rehabilitation, and spinal cord injury medicine.
Dr. Williams’ expertise includes neuro-rehabilitation, spinal cord injury medicine, treatment of spasticity, intrathecal baclofen pump therapy, and pain management. She is a member of the American Board of Physical Medicine and Rehabilitation and the American Spinal Injury Association.
Dr. Williams received her medical degree from Tufts University School of Medicine in Boston. She completed her internal medicine internship and residency at Duke University Medical Center in Durham, North Carolina. Dr. Williams also completed a physical medicine and rehabilitation residency at The Rehabilitation Institute of Chicago at Northwestern University Medical Center in Chicago.
Dr. Williams’ research interests include the use of exoskeletons in the neuro-rehabilitation population and its metabolic impact and potential cardiovascular benefits.
- Residency, Rehabilitation Institute of Chicago, Northwestern University Medical Center, 1987-1990
- Internship, Duke University Medical Center, Internal Medicine, 1981-1984
- MD, Tufts University, 1981
- AB, Vassar College, Biology, 1977
- American Spinal Injury Association
- American Academy of Physical Medicine and Rehabilitation
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology
Date: 11/2025
Authors: Jhodi M. Webster, Ya-Ting Yang, Aidan T. Miller, Asta Zane, Kasandra Scholz, William J. Stone, Nikhita Mudium, Nicole J. Corbin-Stein, Woong-Jai Won, Anna C. Stoll, Kelsey M. Greathouse, Noelle H. Cooper, Lillian F. Long, Phaedra N. Manuel, Jeremy H. Herskowitz, Talene A. Yacoubian, Daniel J. Tyrrell, Ivette M. Sandoval, Fredric P. Manfredsson, Jeffrey H. Kordower, Ashley S. Harms
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Date: 11/2025
Authors: Kevin C. Johnson, An-Chi Tien, Jun Jiang, James McNamara, Yu-Wei Chang, Chelsea Montgomery, Anita DeSantis, Leonel Elena-Sanchez, Yoko Fujita, Seongho Kim, Avishay Spitzer, Paul Gabriel, William F. Flynn, Elise T. Courtois, Amy Hong, Jocelyn Harmon, Yoshie Umemura, Artak Tovmasyan, Jing Li, Shwetal Mehta, Roel G. Verhaak, Nader Sanai
Dispersion-based cognitive intra-individual variability in former American football players: Association with traumatic encephalopathy syndrome, repetitive head impacts, and biomarkers
Date: 11/2025
Authors: Caroline Altaras, Monica T. Ly, Olivia Schultz, William B. Barr, Sarah J. Banks, Jennifer V. Wethe, Yorghos Tripodis, Charles H. Adler, Laura J. Balcer, Charles Bernick, Henrik Zetterberg, Kaj Blennow, Nicholas Ashton, Elaine Peskind, Robert C. Cantu, Michael J. Coleman, Alexander P. Lin, Inga K. Koerte, Sylvain Bouix, Daniel Daneshvar, David W. Dodick, Yonas E. Geda, Douglas L. Katz, Jason L. Weller, Jesse Mez, Joseph N. Palmisano, Brett Martin, Jeffrey L. Cummings, Eric M. Reiman, Martha E. Shenton, Robert A. Stern
Prone transpsoas (PTP)-LLIF approach versus standard LLIF in patients undergoing surgical revision following adult spinal deformity correction surgery
Date: 11/2025
Authors: Luis D. Diaz-Aguilar, Nolan J. Brown, Andrew Nguyen, Saarang Patel, Zach Pennington, Lauren E. Stone, Nicholas S. Hernandez, Julian Gendreau, Mohamed Soliman, Asham Khan, Alexander Padovano, Jeff Ehresman, John Pollina, Rodrigo Amaral, Muhammad M. Abd-El-Barr, Isaac Moss, Tyler G. Smith, Gurvinder Deol, Bryan S. Lee, M Craig McMains, Samuel Joseph, David Schwartz, Luiz Pimenta, Christopher Dibble, Martin H. Pham, Andrew D. Nguyen, William Taylor
Long-Term Results of a Phase 2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone-Positive Breast Cancer.
Date: 09/2025
Authors: David S Lakomy, William R Kennedy, Eric Laugeman, Yi Huang, Julie A Margenthaler, Nusayba A Bagegni, Lindsey Brunt, Maria Thomas, Imran Zoberi
- English
Candyce Williams, MD
Candyce Williams, MD, is a specialist in the Department of Physical Medicine and Neuro-Rehabilitation at Barrow Neurological Institute in Phoenix. She focuses on neuro-rehabilitation and spinal cord injury medicine and is board certified in internal medicine, physical medicine and rehabilitation, and spinal cord injury medicine.
Dr. Williams’ expertise includes neuro-rehabilitation, spinal cord injury medicine, treatment of spasticity, intrathecal baclofen pump therapy, and pain management. She is a member of the American Board of Physical Medicine and Rehabilitation and the American Spinal Injury Association.
Dr. Williams received her medical degree from Tufts University School of Medicine in Boston. She completed her internal medicine internship and residency at Duke University Medical Center in Durham, North Carolina. Dr. Williams also completed a physical medicine and rehabilitation residency at The Rehabilitation Institute of Chicago at Northwestern University Medical Center in Chicago.
Dr. Williams’ research interests include the use of exoskeletons in the neuro-rehabilitation population and its metabolic impact and potential cardiovascular benefits.
- Residency, Rehabilitation Institute of Chicago, Northwestern University Medical Center, 1987-1990
- Internship, Duke University Medical Center, Internal Medicine, 1981-1984
- MD, Tufts University, 1981
- AB, Vassar College, Biology, 1977
- American Spinal Injury Association
- American Academy of Physical Medicine and Rehabilitation
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathology
Date: 11/2025
Authors: Jhodi M. Webster, Ya-Ting Yang, Aidan T. Miller, Asta Zane, Kasandra Scholz, William J. Stone, Nikhita Mudium, Nicole J. Corbin-Stein, Woong-Jai Won, Anna C. Stoll, Kelsey M. Greathouse, Noelle H. Cooper, Lillian F. Long, Phaedra N. Manuel, Jeremy H. Herskowitz, Talene A. Yacoubian, Daniel J. Tyrrell, Ivette M. Sandoval, Fredric P. Manfredsson, Jeffrey H. Kordower, Ashley S. Harms
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Date: 11/2025
Authors: Kevin C. Johnson, An-Chi Tien, Jun Jiang, James McNamara, Yu-Wei Chang, Chelsea Montgomery, Anita DeSantis, Leonel Elena-Sanchez, Yoko Fujita, Seongho Kim, Avishay Spitzer, Paul Gabriel, William F. Flynn, Elise T. Courtois, Amy Hong, Jocelyn Harmon, Yoshie Umemura, Artak Tovmasyan, Jing Li, Shwetal Mehta, Roel G. Verhaak, Nader Sanai
Dispersion-based cognitive intra-individual variability in former American football players: Association with traumatic encephalopathy syndrome, repetitive head impacts, and biomarkers
Date: 11/2025
Authors: Caroline Altaras, Monica T. Ly, Olivia Schultz, William B. Barr, Sarah J. Banks, Jennifer V. Wethe, Yorghos Tripodis, Charles H. Adler, Laura J. Balcer, Charles Bernick, Henrik Zetterberg, Kaj Blennow, Nicholas Ashton, Elaine Peskind, Robert C. Cantu, Michael J. Coleman, Alexander P. Lin, Inga K. Koerte, Sylvain Bouix, Daniel Daneshvar, David W. Dodick, Yonas E. Geda, Douglas L. Katz, Jason L. Weller, Jesse Mez, Joseph N. Palmisano, Brett Martin, Jeffrey L. Cummings, Eric M. Reiman, Martha E. Shenton, Robert A. Stern
Prone transpsoas (PTP)-LLIF approach versus standard LLIF in patients undergoing surgical revision following adult spinal deformity correction surgery
Date: 11/2025
Authors: Luis D. Diaz-Aguilar, Nolan J. Brown, Andrew Nguyen, Saarang Patel, Zach Pennington, Lauren E. Stone, Nicholas S. Hernandez, Julian Gendreau, Mohamed Soliman, Asham Khan, Alexander Padovano, Jeff Ehresman, John Pollina, Rodrigo Amaral, Muhammad M. Abd-El-Barr, Isaac Moss, Tyler G. Smith, Gurvinder Deol, Bryan S. Lee, M Craig McMains, Samuel Joseph, David Schwartz, Luiz Pimenta, Christopher Dibble, Martin H. Pham, Andrew D. Nguyen, William Taylor
Long-Term Results of a Phase 2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone-Positive Breast Cancer.
Date: 09/2025
Authors: David S Lakomy, William R Kennedy, Eric Laugeman, Yi Huang, Julie A Margenthaler, Nusayba A Bagegni, Lindsey Brunt, Maria Thomas, Imran Zoberi
- English